Currently available molluscicides.
Views about the importance of the role of molluscicides in the integrated control of human schistosomiasis have passed through cyclical changes over the past 15 years. For a time, it was hoped that chemotherapy alone would achieve significant morbidity control; it has since become clear that molluscicides cannot be easily excluded from the anti-schistosome armoury. In this review, Sheena Perrett and Phil Whitfield summarize the evidence for this conclusion and provide an overview of currently available synthetic molluscicides and those natural product molluscicides currently under active investigation.
Infection and Immunity Research Group, Division of Life Sciences, King's College London, Campden Hill Road, London, UK. Sheen.perrett@kcl.ac.uk
S
S
Perrett
P J
PJ
Whitfield